Literature DB >> 23123411

Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3.

Alessandro Matte1, Mariarita Bertoldi, Narla Mohandas, Xiuli An, Antonella Bugatti, Anna Maria Brunati, Marco Rusnati, Elena Tibaldi, Angela Siciliano, Franco Turrini, Silverio Perrotta, Lucia De Franceschi.   

Abstract

Band 3 (B3), the anion transporter, is an integral membrane protein that plays a key structural role by anchoring the plasma membrane to the spectrin-based membrane skeleton in the red cell. In addition, it also plays a critical role in the assembly of glycolytic enzymes to regulate red cell metabolism. However, its ability to recruit proteins that can prevent membrane oxidation has not been previously explored. In this study, using a variety of experimental approaches including cross-linking studies, fluorescence and dichroic measurements, surface plasmon resonance analysis, and proteolytic digestion assays, we document that the antioxidant protein peroxiredoxin-2 (PRDX2), the third most abundant cytoplasmic protein in RBCs, interacts with the cytoplasmic domain of B3. The surface electrostatic potential analysis and stoichiometry measurements revealed that the N-terminal peptide of B3 is involved in the interaction. PRDX2 underwent a conformational change upon its binding to B3 without losing its peroxidase activity. Hemichrome formation induced by phenylhydrazine of RBCs prevented membrane association of PRDX2, implying overlapping binding sites. Documentation of the absence of binding of PRDX2 to B3 Neapolis red cell membranes, in which the initial N-terminal 11 amino acids are deleted, enabled us to conclude that PRDX2 binds to the N-terminal cytoplasmic domain of B3 and that the first 11 amino acids of this domain are crucial for PRDX2 membrane association in intact RBCs. These findings imply yet another important role for B3 in regulating red cell membrane function.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123411     DOI: 10.1016/j.freeradbiomed.2012.10.543

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  31 in total

Review 1.  Purinergic control of red blood cell metabolism: novel strategies to improve red cell storage quality.

Authors:  Kaiqi Sun; Angelo D'alessandro; Yang Xia
Journal:  Blood Transfus       Date:  2017-04-12       Impact factor: 3.443

2.  Global transformation of erythrocyte properties via engagement of an SH2-like sequence in band 3.

Authors:  Estela Puchulu-Campanella; Francesco M Turrini; Yen-Hsing Li; Philip S Low
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-15       Impact factor: 11.205

Review 3.  Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.

Authors:  Viktoria Kuhn; Lukas Diederich; T C Stevenson Keller; Christian M Kramer; Wiebke Lückstädt; Christina Panknin; Tatsiana Suvorava; Brant E Isakson; Malte Kelm; Miriam M Cortese-Krott
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

4.  Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.

Authors:  Alessandro Matte; Enrica Federti; Michael Winter; Annette Koerner; Anja Harmeier; Norman Mazer; Tomas Tomka; Maria Luisa Di Paolo; Luigia De Falco; Immacolata Andolfo; Elisabetta Beneduce; Achille Iolascon; Alejandra Macias-Garcia; Jane-Jane Chen; Anne Janin; Christhophe Lebouef; Franco Turrini; Carlo Brugnara; Lucia De Franceschi
Journal:  JCI Insight       Date:  2019-11-14

5.  Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion.

Authors:  Lisa Mullen; Eva-Maria Hanschmann; Christopher Horst Lillig; Leonore A Herzenberg; Pietro Ghezzi
Journal:  Mol Med       Date:  2015-02-13       Impact factor: 6.354

Review 6.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

7.  Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice.

Authors:  Sara Santos Franco; Luigia De Falco; Saghi Ghaffari; Carlo Brugnara; David A Sinclair; Alessandro Matte'; Achille Iolascon; Narla Mohandas; Mariarita Bertoldi; Xiuli An; Angela Siciliano; Pauline Rimmelé; Maria Domenica Cappellini; Shaday Michan; Elisa Zoratti; Janin Anne; Lucia De Franceschi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

8.  A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis.

Authors:  Francesca Lupo; Elena Tibaldi; Alessandro Matte; Alok K Sharma; Anna Maria Brunati; Seth L Alper; Carlo Zancanaro; Donatella Benati; Angela Siciliano; Mariarita Bertoldi; Francesca Zonta; Alexander Storch; Ruth H Walker; Adrian Danek; Benedikt Bader; Andreas Hermann; Lucia De Franceschi
Journal:  Blood       Date:  2016-10-14       Impact factor: 22.113

Review 9.  Oxidative stress in β-thalassaemia and sickle cell disease.

Authors:  S Voskou; M Aslan; P Fanis; M Phylactides; M Kleanthous
Journal:  Redox Biol       Date:  2015-08-01       Impact factor: 11.799

10.  Advances in T-cell epitope engineering.

Authors:  Johanne M Pentier; Andrew K Sewell; John J Miles
Journal:  Front Immunol       Date:  2013-06-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.